Hepatitis Treatment Hope: Report Finds Lack of Access
Hepatitis C Elimination in Australia Faces Hurdles despite Treatment Success
Hepatitis C treatment has seen remarkable success in Australia, with a important majority of people who contracted the virus no longer injecting drugs. However, stigma and discrimination remain persistent barriers, hindering access to vital care for many, according to a recent report.
The Shifting Landscape of Hepatitis C Transmission
A report highlights that while treatment efforts have been effective in reaching those who inject drugs, a ample portion of people living with hepatitis C in Australia contracted the virus through other means. Out of 100 individuals with hepatitis C, 84 no longer inject drugs or acquired the infection through different pathways.
“The work to ensure people who inject drugs are receiving the cure has been effective,which is why we’re seeing a change in the population,” stated Clynes,a key figure in the report’s findings. This success underscores the importance of targeted interventions for this demographic.
Beyond Injecting Drug Use: Other Transmission Routes
The report also sheds light on how individuals contract hepatitis C outside of injecting drug use. These routes can include:
unsafe tattooing: Procedures performed with unsterilized equipment.
Blood transfusions before 1990: Before rigorous screening protocols were implemented.
Medical or dental procedures: Particularly in countries with less stringent blood safety regulations.
Clynes noted that individuals who contracted hepatitis C through these less common pathways might potentially be less likely to engage with medical services,presenting a new challenge in the fight for elimination.
Urgent action Needed to Meet Elimination Goals
To achieve Australia’s commitment to eliminating viral hepatitis by 2030, in line with global World Health Association (WHO) targets, the report urges immediate action. Key recommendations include:
Population-wide testing: Implementing widespread testing to identify undiagnosed cases.
Targeted education: Raising awareness about hepatitis C transmission and prevention, especially for at-risk groups.
Culturally safe care pathways: Developing and implementing healthcare services that are sensitive to the diverse needs and backgrounds of all affected individuals.
Without these crucial steps, australia risks falling short of its ambitious elimination goals. The ongoing stigma associated with injecting drug use continues to cast a long shadow, impacting the ability of all people living with hepatitis C to access the treatment and support they need. Addressing this stigma, alongside expanding testing and improving access to care, is paramount to a hepatitis C-free future for Australia.